The Parkinson's-Reversing Breakthrough

Treatment Options for Parkinson Disease

Get Instant Access

Deep Brain stimulation study group. (2001). Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. New Engl J Med, 345, 956-963.

Agrawal, A.K., Chaturvedi, R.K., Shukla, S., Seth, K., Chauhan, S., Ahmad, A. and Seth, P.K. (2004). Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease. J Chem Neuroanat, 28, 253-264.

Ahlskog, J.E. and Muenter, M.D. (2001). Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord, 16, 448-458.

Altar, C.A., Boylan, C.B., Fritsche, M., Jones, B.E., Jackson, C., Wiegand, S.J., Lindsay, R.M. and Hyman, C. (1994). Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. JNeurochem, 63, 1021-1032.

Arjona, V, Minguez-Castellanos, A., Montoro, R.J., Ortega, A., Escamilla, F., Toledo-Aral, J.J., Pardal, R., Mendez-Ferrer, S., Martin, J.M., Perez, M., Katati, M.J., Valencia, E., Garcia, T. and Lopez-Barneo, J. (2003). Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease. Neurosurgery, 53, 321-328, discussion 328-330.

Baker, K.A., Sadi, D., Hong, M. and Mendez, I. (2000). Simultaneous intrastriatal and intranigral dopaminergic grafts in the Parkinsonian rat model: role of the intranigral graft. J Comp Neurol, 426, 106-116.

Baker-Cairns, B.J., Sloan, D.J., Broadwell, R.D., Puklavec, M. and Charlton, H.M. (1996). Contributions of donor and host blood vessels in CNS allografts. Exp Neurol, 142, 36-46.

Barker, R.A., Dunnett, S.B., Faissner, A. and Fawcett, J.W. (1996). The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesen-cephalon to the striatum. Exp Neurol, 141, 79-93.

Bensadoun, J.C., Deglon, N., Tseng, J.L., Ridet, J.L., Zurn, A.D. and Aebischer, P. (2000). Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF. Exp Neurol, 164, 15-24.

Bjorklund, A. and Stenevi, U. (1971). Growth of central cate-cholamine neurones into smooth muscle grafts in the rat mesencephalon. Brain Res, 31, 1-20.

Bjorklund, A., Dunnett, S.B., Brundin, P., Stoessl, A.J., Freed, C.R., Breeze, R.E., Levivier, M., Peschanski, M., Studer, L. and

Barker, R. (2003). Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol, 2, 437-445.

Bjorklund, L.M., Sanchez-Pernaute, R., Chung, S., Andersson, T., Chen, I.Y., McNaught, K.S., Brownell, A.L., Jenkins, B.G., Wahlestedt, C., Kim, K.S. and Isacson, O. (2002). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA, 99, 2344-2349.

Bohn, M.C., Goldstein, M. and Black, I.B. (1982). Expression of phenylethanolamine N-methyltransferase in rat sympathetic ganglia and extra-adrenal chromaffin tissue. Dev Biol, 89, 299-308.

Boll, J.B., Geist, M.A., Kaminski Schierle, G.S., Petersen, K., Leist, M. and Vaudano, E. (2004). Improvement of embryonic dopaminergic neurone survival in culture and after grafting into the striatum of hemiparkinsonian rats by CEP-1347. J Neurochem, 88, 698-707.

Brundin, P., Nilsson, O.G., Strecker, R.E., Lindvall, O., Astedt, B. and Bjorklund, A. (1986). Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res, 65, 235-240.

Brundin, P., Strecker, R.E., Widner, H., Clarke, D.J., Nilsson, O.G., Astedt, B., Lindvall, O. and Bjorklund, A. (1988). Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp Brain Res, 70, 192-208.

Brundin, P., Karlsson, J., Emgard, M., Schierle, G.S., Hansson, O., Petersen, A. and Castilho, R.F. (2000a). Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant, 9, 179-195.

Brundin, P., Pogarell, O., Hagell, P., Piccini, P., Widner, H., Schrag, A., Kupsch, A., Crabb, L., Odin, P., Gustavii, B., Bjorklund, A., Brooks, D.J., Marsden, C.D., Oertel, W.H., Quinn, N.P., Rehncrona, S. and Lindvall, O. (2000b). Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain, 123(Part 7), 1380-1390.

Burnstein, R.M., Foltynie, T., He, X., Menon, D.K., Svendsen, C.N. and Caldwell, M.A. (2004). Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease. Int J Biochem Cell Biol, 36, 702-713.

Carvey, P.M., Ling, Z.D., Sortwell, C.E., Pitzer, M.R., McGuire, S.O., Storch, A. and Collier, T.J. (2001). A clonal line of mesen-cephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp Neurol, 171, 98-108.

Chun, H.S., Gibson, G.E., Degiorgio, L.A., Zhang, H., Kidd, V.J. and Son, J.H. (2001). Dopaminergic cell death induced by

MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism. J Neurochem, 76, 1010-1021.

Cohen, J. (1994). New fight over fetal tissue grafts. Science, 263, 600-601.

Collier, T.J., Sortwell, C.E., Elsworth, J.D., Taylor, J.R., Roth, R.H., Sladek Jr., J.R. and Redmond Jr., D.E. (2002). Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. J Comp Neurol, 442, 320-330.

de la Fuente-Fernandez, R., Ruth, T.J., Sossi, V., Schulzer, M., Calne, D.B. and Stoessl, A.J. (2001). Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science, 293, 1164-1166.

Deacon, T., Schumacher, J., Dinsmore, J., Thomas, C., Palmer, P., Kott, S., Edge, A., Penney, D., Kassissieh, S., Dempsey, P. and isacson, O. (1997). Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med, 3, 350-353.

Dezawa, M., Kanno, H., Hoshino, M., Cho, H., Matsumoto, N., itokazu, Y., Tajima, N., Yamada, H., Sawada, H., ishikawa, H., Mimura, T., Kitada, M., Suzuki, Y. and ide, C. (2004). Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest, 113, 1701-1710.

Drucker-Colin, R. and Verdugo-Diaz, L. (2004). Cell transplantation for Parkinson's disease: present status. Cell Mol Neurobiol, 24, 301-316.

Duan, W.M., Widner, H., Bjorklund, A. and Brundin, P. (1993). Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: will the second graft be rejected? Neuroscience, 5?, 261-274.

Dunnett, S.B. and Annett, L.E. (1991). Nigral transplants in primate models of parkinsonism. in: Intracerebral Trans-plantation in Movement Disorders (eds Lindvall, O., Bjorklund, A. and Widermer, H.R.), Elsevier Science Publishers, New York.

Dunnett, S.B., Bjorklund, A., Schmidt, R.H., Stenevi, U. and iversen, S.D. (1983). intracerebral grafting of neuronal cell suspensions. iV Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol Scand Suppl, 522, 29-37.

Dunnett, S.B., Hernandez, T.D., Summerfield, A., Jones, G.H. and Arbuthnott, G. (1988). Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues. Exp Brain Res, ?1, 411-424.

Espejo, E.F., Gonzalez-Albo, M.C., Moraes, J.P., El Banoua, F., Flores, JA. and Caraballo, i. (2001). Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor betal-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ. JNeurosci, 21, 9888-9895.

Fahn, S., Oakes, D., Shoulson, I., Kieburtz, K., Rudolph, A., Lang, A., Olanow, C.W., Tanner, C. and Marek, K. (2004). Levodopa and the progression of Parkinson's disease. New Engl J Med, 351, 2498-2508.

Fawcett, J.W., Barker, R.A and Dunnett, S.B. (1995). Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon. Exp Brain Res, 106, 275-282.

Fisher, L.J. and Gage, F.H. (1993). Grafting in the mammalian central nervous system. Physiol Rev, 73, 583-616.

Freed, C.R., Breeze, R.E., Rosenberg, N.L., Schneck, S.A., Kriek, E., Qi, J.X., Lone, T., Zhang, Y.B., Snyder, J.A., Wells, T.H., et al. (1992). Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. New Engl J Med, 327, 1549-1555.

Freed, C.R., Greene, P.E., Breeze, R.E., Tsai, W.Y., Dumouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J.Q., Eidelberg, D. and Fahn, S. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson's disease. New Engl J Med, 344, 710-719.

Freed, C.R., Breeze, R.E., Fahn, S. and Eidelberg, D. (2004). Preoperative response to levodopa is the best predictor of transplant outcome. Ann Neurol, 55, 896, author reply 896-897.

Freeman, T.B., Olanow, C.W., Hauser, R.A., Nauert, G.M., Smith, D.A., Borlongan, C.Y, Sanberg, P.R., Holt, D.A., Kordower, J.H., Vingerhoets, F.J., et al. (1995). Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol, 38, 379-388.

Freeman, T.B., Vawter, D.E., Leaverton, P.E., Godbold, J.H., Hauser, R.A., Goetz, C.G. and Olanow, C.W. (1999). Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med, 341, 988-992.

Gage, F.H. (2000). Mammalian neural stem cells. Science, 287, 1433-1438.

Gash, D.M., Zhang, Z., Cass, W.A., Ovadia, A., Simmerman, L., Martin, D., Russell, D., Collins, F., Hoffer, B.J. and Gerhardt, G.A. (1995). Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys. J Comp Neurol, 363, 345-358.

Gash, D.M., Zhang, Z., Ovadia, A., Cass, W.A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P.A., Collins, F., Hoffer, B.J. and Gerhardt, G.A. (1996). Functional recovery in parkin-sonian monkeys treated with GDNF. Nature, 380, 252-255.

Gearan, T., Castillo, O.A. and Schwarzschild, MA. (2001). The parkinsonian neurotoxin, MPP+ induces phosphorylated c-Jun in dopaminergric neurons of mesencephalic cultures. Parkinsonism Relat Disord, 8, 19-22.

Goetz, C.G., Olanow, C.W., Koller, W.C., Penn, R.D., Cahill, D., Morantz, R., Stebbins, G., Tanner, C.M., Klawans, H.L. and Shannon, K.M. (1989). Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. New Engl J Med, 320, 337-341.

Gordon, P.H., Yu, Q., Qualls, C., Winfield, H., Dillon, S., Greene, P.E., Fahn, S., Breeze, R.E., Freed, C.R. and Pullman, S.L. (2004). Reaction time and movement time after embryonic cell implantation in Parkinson disease. Arch Neurol, 61, 858-861.

Granholm, A.C., Mott, J.L., Bowenkamp, K., Eken, S., Henry, S., Hoffer, B.J., Lapchak, P.A., Palmer, M.R., Van Horne, C. and Gerhardt, G.A. (1997). Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp Brain Res, 116, 29-38.

Hagell, P., Schrag, A., Piccini, P., Jahanshahi, M., Brown, R., Rehncrona, S., Widner, H., Brundin, P., Rothwell, J.C., Odin, P., Wenning, G.K., Morrish, P., Gustavii, B., Bjorklund, A., Brooks, D.J., Marsden, C.D., Quinn, N.P. and Lindvall, O. (1999). Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain, 122(Pt 6), 1121-1132.

Hagell, P., Piccini, P., Bjorklund, A., Brundin, P., Rehncrona, S., Widner, H., Crabb, L., Pavese, N., Oertel, W.H., Quinn, N., Brooks, D.J. and Lindvall, O. (2002). Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci, 5, 627-628.

Harris, C.A., Deshmukh, M., Tsui-Pierchala, B., Maroney, A.C. and Johnson Jr., E.M. (2002). Inhibition of the c-Jun N-terminal kinase signaling pathway by the mixed lineage kinase inhibitor CEP-1347 (KT7515) preserves metabolism and growth of trophic factor-deprived neurons. J Neurosci, 22, 103-113.

Hauser, R.A., Freeman, T.B., Snow, B.J., Nauert, M., Gauger, L., Kordower, J.H. and Olanow, C.W. (1999). Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol, 56, 179-187.

Itakura, T., Uematsu, Y., Nakao, N., Nakai, E. and Nakai, K. (1997). Transplantation of autologous sympathetic ganglion into the brain with Parkinson's disease. Long-term follow-up of 35 cases. StereotactFunct Neurosurg, 69, 112-115.

Kim, S.Y.H., Frank, S., Holloway, R., Zimmerman, C., Wilson, R. and Kierburtz, K. (2005). Science and ethics of sham surgery: a survey of Parkinson's disease clinical researchers. Arch Neurol, 62, 1357-1360.

Kim, T.E., Lee, H.S., Lee, Y.B., Hong, S.H., Lee, Y.S., Ichinose, H., Kim, S.U. and Lee, M.A. (2003). Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotypes in the Nurr1-overexpressing neural stem cell. Biochem Biophys Res Commun, 305, 1040-1048.

Kirik, D., Winkler, C. and Bjorklund, A. (2001). Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J Neurosci, 21, 2889-2896.

Kordower, J.H., Freeman, T.B., Snow, B.J., Vingerhoets, F.J., Mufson, E.J., Sanberg, P.R., Hauser, R.A., Smith, D.A., Nauert, G.M., Perl, D.P., et al. (1995). Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. New Engl J Med, 332, 1118-1124.

Kordower, J.H., Rosenstein, J.M., Collier, T.J., Burke, M.A., Chen, E.Y., Li, J.M., Martel, L., Levey, A.E., Mufson, E.J., Freeman, T.B. and Olanow, C.W. (1996). Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol, 370, 203-230.

Kordower, J.H., Styren, S., Clarke, M., Dekosky, S.T., Olanow, C.W. and Freeman, T.B. (1997). Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants. Cell Transplant, 6, 213-219.

Kordower, J.H., Freeman, T.B., Chen, E.Y., Mufson, E.J., Sanberg, P.R., Hauser, RA, Snow, B. and Olanow, C.W. (1998). Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord, 13, 383-393.

Kordower, J.H., Emborg, M.E., Bloch, J., Ma, S.Y., Chu, Y., Leventhal, L., McBride, J., Chen, E.Y., Palfi, S., Roitberg, B.Z., Brown, W.D., Holden, J.E., Pyzalski, R., Taylor, M.D., Carvey, P., Ling, Z., Trono, D., Hantraye, P., Deglon, N. and Aebischer, P. (2000). Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science, 290, 767-773.

Lang, A.E. and Lozano, A.M. (1998). Parkinson's disease. First of two parts. New Engl J Med, 339, 1044-1053.

Lang, A.E. and Obeso, JA. (2004a). Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol, 3, 309-316.

Lang, A.E. and Obeso, J.A. (2004b). Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease. Ann Neurol, 55, 761-765.

Lee, C.S., Cenci, MA., Schulzer, M. and Bjorklund, A. (2000). Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain, 123(Pt 7), 1365-1379.

Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S. and Collins, F. (1993). GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 260, 1130-1132.

Lindvall, O., Backlund, E.O., Farde, L., Sedvall, G., Freedman, R., Hoffer, B., Nobin, A., Seiger, A. and Olson, L. (1987). Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol, 22, 457-468.

Lindvall, O., Brundin, P., Widner, H., Rehncrona, S., Gustavii, B., Frackowiak, R., Leenders, K.L., Sawle, G., Rothwell, J.C., Marsden, C.D., et al. (1990). Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science, 247, 574-577.

Lindvall, O., Widner, H., Rehncrona, S., Brundin, P., Odin, P., Gustavii, B., Frackowiak, R., Leenders, K.L., Sawle, G., Rothwell, J.C., et al. (1992). Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neuro-physiological observations in two patients with putaminal implants. Ann Neurol, 31, 155-165.

Lindvall, O., Sawle, G., Widner, H., Rothwell, J.C., Bjorklund, A., Brooks, D., Brundin, P., Frackowiak, R., Marsden, C.D., Odin, P., et al. (1994). Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol, 35, 172-180.

Luquin, M.R., Montoro, R.J., Guillen, J., Saldise, L., Insausti, R., Del Rio, J. and Lopez-Barneo, J. (1999). Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen. Neuron, 22, 743-750.

Ma, Y., Feigin, A., Dhawan, V, Fukuda, M., Shi, Q., Greene, P., Breeze, R., Fahn, S., Freed, C. and Eidelberg, D. (2002). Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol, 52, 628-634.

Macklin, R. (1999). The ethical problems with sham surgery in clinical research. New Engl J Med,341, 992-996.

Madrazo, I., Drucker-Colin, R., Diaz, V, Martinez-Mata, J., Torres, C. and Becerril, J.J. (1987). Open microsurgical auto-graft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. New Engl J Med, 316, 831-834.

Magavi, S.S. and Macklis, J.D. (2001). Manipulation of neural precursors in situ: induction of neurogenesis in the neocor-tex of adult mice. Neuropsychopharmacology, 25, 816-835.

Marsden, C.D. and Parkes, J.D. (1976). "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet, 1 , 292-296.

McRae, C., Cherin, E., YAmazaki, T.G., Diem, G., Vo, A.H., Russell, D., Ellgring, J.H., Fahn, S., Greene, P., Dillon, S., Winfield, H., Bjugstad, K.B. and Freed, C.R. (2004). Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry, 61, 412-420.

Mendez, I., Dagher, A., Hong, M., Gaudet, P., Weerasinghe, S., McAlister, V., King, D., Desrosiers, J., Darvesh, S., Acorn, T. and Robertson, H. (2002). Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. JNeurosurg, 96, 589-596.

Mendez, I., Sanchez-Pernaute, R., Cooper, O., Vinuela, A., Ferrari, D., Bjorklund, L., Dagher, A. and Isacson, O. (2GG5). Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain, lT8, 1498-151G.

Meyer, M., Widmer, H.R., Wagner, B., Guzman, R., Evtouchenko, L., Seiler, R.W. and Spenger, C. (1998). Comparison of mesen-cephalic free-floating tissue culture grafts and cell suspension grafts in the 6-hydroxydopamine-lesioned rat. Exp Brain Res, ll9, 345-355.

Murakata, C., Kaneko, M., Gessner, G., Angeles, T.S., Ator, M.A., O'Kane, T.M., McKenna, B.A., Thomas, B.A., Mathiasen, J.R., Saporito, M.S., Bozyczko-Coyne, D. and Hudkins, R.L. (2GG2). Mixed lineage kinase activity of indolocarbazole analogues. Bioorg Med Chem Lett, lT, 147-15G.

Nakao, N., Kakishita, K., Uematsu, Y., Yoshimasu, T., Bessho, T., Nakai, K., Naito, Y. and Itakura, T. (2GG1). Enhancement of the response to levodopa therapy after intrastriatal transplantation of autologous sympathetic neurons in patients with Parkinson disease. J Neurosurg, 9S, 275-284.

Nikkhah, G., Odin, P., Smits, A., Tingstrom, A., Othberg, A., Brundin, P., Funa, K. and Lindvall, O. (1993). Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture. Exp Brain Res, 9T, 516-523.

Nikkhah, G., Cunningham, M.G., Jodicke, A., Knappe, U. and Bjorklund, A. (1994). Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res, 6SS, 133-143.

Obeso, J.A., Rodriguez-Oroz, M.C., Rodriguez, M., Lanciego, J.L., Artieda, J., Gonzalo, N. and Olanow, C.W. (2GGG). Pathophysio-logy of the basal ganglia in Parkinson's disease. Trends Neurosci, TS, S8-S19.

Olanow, C.W. (2GG3). Present and future directions in the management of motor complications in patients with advanced PD. Neurology, 6l, S24-S33.

Olanow, C.W. (2GG4). The scientific basis for the current treatment of Parkinson's disease. Annu Rev Med, SS, 41-6G.

Olanow, C.W. (2GG5). Double-blind, placebo-controlled trials for surgical interventions in Parkinson's disease. Arch Neurol, 6T, 1343-1344.

Olanow, C.W., Koller, W., Goetz, C.G., Stebbins, G.T., Cahill, D.W., Gauger, L.L., Morantz, R., Penn, R.D., Tanner, C.M., Klawans, H.L., et al. (199G). Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results. Arch Neurol, 47, 1286-1289.

Olanow, C.W., Kordower, J.H. and Freeman, T.B. (1996). Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci, l9, 1G2-1G9.

Olanow, C.W., Watts, R.L. and Koller, W.C. (2001). An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology, 56, S1-S88.

Olanow, C.W., Goetz, C.G., Kordower, J.H., Stoessl, A.J., Sossi, V, Brin, M.F., Shannon, K.M., Nauert, G.M., Perl, D.P., Godbold, J. and Freeman, T.B. (2003). A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol, 54, 403-414.

Olanow, C.W., Agid, Y., Mizuno, Y., Albanese, A., Bonucelli, U., Damier, P., de Yebenes, J., Gershanik, O., Guttman, M., Grandas, F., Hallett, M., Hornykiewicz, O., Jenner, P., Katzenschlager, R., Langston, W.J., Lewitt, P., Melamed, E., Mena, M.A., Michel, P.P., Mytilineou, C., Obeso, J.A., Poewe, W., Quinn, N., Raisman-Vozari, R., Rajput, A.H., Rascol, O., Sampaio, C. and Stocchi, F. (2004). Levodopa in the treatment of Parkinson's disease: current controversies. Mov Disord, 19, 997-1005.

Park, C.H., Minn, Y.K., Lee, J.Y., Choi, D.H., Chang, M.Y., Shim, J.W., Ko, J.Y., Koh, H.C., Kang, M.J., Kang, J.S., Rhie, D.J., Lee, Y.S., Son, H., Moon, S.Y., Kim, K.S. and LEE, S.H. (2005). In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem, 92, 1265-1276.

Perlow, M.J., Freed, W.J., Hoffer, B.J., Seiger, A., Olson, L. and Wyatt, R.J. (1979). Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science, 204, 643-647.

Perrier, A.L., Tabar, V., Barberi, T., Rubio, M.E., Bruses, J., Topf, N., Harrison, N.L. and Studer, L. (2004). Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA, 101, 12543-12548.

Peschanski, M., Defer, G., N'Guyen, J.P., Ricolfi, F., Monfort, J.C., Remy, P., Geny, C., Samson, Y., Hantraye, P., Jeny, R., et al.

(1994). Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesen-cephalon. Brain, 117(Pt 3), 487-499.

Peterson, D.I., Price, M.L. and Small, C.S. (1989). Autopsy findings in a patient who had an adrenal-to-brain transplant for Parkinson's disease. Neurology, 39, 235-238.

Piccini, P., Lindvall, O., Bjorklund, A., Brundin, P., Hagell, P., Ceravolo, R., Oertel, W., Quinn, N., Samuel, M., Rehncrona, S., Widner, H. and Brooks, D.J. (2000). Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol, 48, 689-695.

Remy, P., Samson, Y., Hantraye, P., Fontaine, A., Defer, G., Mangin, J.F., Fenelon, G., Geny, C., Ricolfi, F., Frouin, V., et al.

(1995). Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol, 38, 580-588.

Rodriguez, M.C., Obeso, JA and Olanow, C.W. (1998). Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol, 44, S175-S188.

Schierle, G.S., Hansson, O., Leist, M., Nicotera, P., Widner, H. and Brundin, P. (1999). Caspase inhibition reduces apopto-sis and increases survival of nigral transplants. Nat Med, 5, 97-100.

Schmidt, R.H., Ingvar, M., Lindvall, O., Stenevi, U. and Bjorklund, A. (1982). Functional activity of substantia nigra grafts reinnervating the striatum: neurotransmitter metabolism and [14C]2-deoxy-d-glucose autoradiography. J Neurochem, 38, 737-748.

Schumacher, J.M., Ellias, S.A., Palmer, E.P., Kott, H.S., Dinsmore, J., Dempsey, P.K., Fischman, A.J., Thomas, C., Feldman, R.G., Kassissieh, S., Raineri, R., Manhart, C., Penney, D., Fink, J.S. and Isacson, O. (2000). Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology, 54, 1042-1050.

Shinoda, M., Hudson, J.L., Stromberg, I., Hoffer, B.J., Moorhead, J.W. and Olson, L. (1995). Allogeneic grafts of fetal dopamine neurons: immunological reactions following active and adoptive immunizations. Brain Res, 680, 180-195.

Shinoda, M., Hudson, J.L., Stromberg, I., Hoffer, B.J., Moorhead, J.W. and Olson, L. (1996). Microglial cell responses to fetal ventral mesencephalic tissue grafting and to active and adoptive immunizations. Exp Neurol, 141, 173-180.

Shukla, S., Agrawal, A.K., Chaturvedi, R.K., Seth, K., Srivastava, N., Sinha, C., Shukla, Y., Khanna, YK. and Seth, P.K. (2004). Co-transplantation of carotid body and ventral mesen-cephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease. J Neurochem, 91, 274-284.

Sortwell, C.E., Pitzer, M.R. and Collier, T.J. (2000). Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival. Exp Neurol, 165, 268-277.

Sortwell, C.E., Collier, T.J., Camargo, M.D. and Pitzer, M.R. (2004). An in vitro interval before transplantation of mesen-cephalic reaggregates does not compromise survival or functionality. Exp Neurol, 187, 58-64.

Storch, A., Sabolek, M., Milosevic, J., Schwarz, S.C. and Schwarz, J. (2004). Midbrain-derived neural stem cells: from basic science to therapeutic approaches. Cell Tissue Res, 318, 15-22.

Studer, L., Spenger, C., Seiler, R.W., Altar, C.A., Lindsay, R.M. and Hyman, C. (1995). Comparison of the effects of the neurotrophins on the morphological structure of dopami-nergic neurons in cultures of rat substantia nigra. Eur

Subramanian, T., Marchionini, D., Pother, E.M. and Cornfeldt, M.L. (2002). Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkin-sonian rats ameliorates behavioral deficits without provoking a host immune response. Cell Transplant, 11, 207-214.

Takagi, Y., Takahashi, J., Saiki, H., Morizane, A., Hayashi, T., Kishi, Y., Fukuda, H., Okamoto, Y., Koyanagi, M., Ideguchi, M., Hayashi, H., Imazato, T., Kawasaki, H., Suemori, H., Omachi, S., Iida, H., Itoh, N., Nakatsuji, N., Sasai, Y. and Hashimoto, N. (2005). Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest, 115, 102-109.

Timmer, M., Muller-Ostermeyer, F., Kloth, V, Winkler, C., Grothe, C. and Nikkhah, G. (2004). Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms. Exp Neurol, 187, 118-136.

Toledo-Aral, J.J., Mendez-Ferrer, S., Pardal, R., Echevarria, M. and Lopez-Barneo, J. (2003). Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats. J Neurosci, 23, 141-148.

Tooyama, I., McGeer, E.G., Kawamata, T., Kimura, H. and McGeer, P.L. (1994). Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrasts with loss in Parkinson's disease. Brain Res, 656, 165-168.

Wang, X., Lu, Y., Zhang, H., Wang, K., He, Q., Wang, Y., Liu, X., Li, L. and Wang, X. (2004). Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease. Int JDev Neurosci, 22, 175-183.

Watts, R.L., Raiser, C.D., Stover, N.P., Cornfeldt, M.L., Schweikert, A.W., Allen, R.C., Subramanian, T., Doudet, D., Honey, C.R. and Bakay, R.A. (2003). Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease. J Neural Transm Suppl, 215-227.

Wenning, G.K., Odin, P., Morrish, P., Rehncrona, S., Widner, H., Brundin, P., Rothwell, J.C., Brown, R., Gustavii, B., Hagell, P., Jahanshahi, M., Sawle, G., Bjorklund, A., Brooks, D.J., Marsden, C.D., Quinn, N.P. and Lindvall, O. (1997). Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol, 42, 95-107.

Winkler, C., Sauer, H., Lee, C.S. and Bjorklund, A. (1996). Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci, 16, 7206-7215.

Winkler, C., Kirik, D. and Bjorklund, A. (2005). Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci, 28, 86-92.

Wuerthele, S.M., Freed, W.J., Olson, L., Morihisa, J., Spoor, L., Wyatt, R.J. and Hoffer, B.J. (1981). Effect of dopamine agonists and antagonists on the electrical activity of substantia nigra neurons transplanted into the lateral ventricle of the rat. Exp Brain Res, 44, 1-10.

Xu, Z., Maroney, A.C., Dobrzanski, P., Kukekov, N.V. and Greene, L.A. (2001). The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. Mol Cell Biol, 21, 4713-4724.

Yang, M., Stull, N.D., Berk, M.A., Snyder, E.Y. and Iacovitti, L. (2002). Neural stem cells spontaneously express dopami-nergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat. Exp Neurol, 177, 50-60.

Yasuhara, T., Shingo, T., Kobayashi, K., Takeuchi, A., Yano, A., Muraoka, K., Matsui, T., Miyoshi, Y., Hamada, H. and Date, I. (2004). Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur J Neurosci, 19, 1494-1504.

Yoshizaki, T., Inaji, M., Kouike, H., Shimazaki, T., Sawamoto, K., Ando, K., Date, I., Kobayashi, K., Suhara, T., Uchiyama, Y. and Okano, H. (2004). Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells. Neurosci Lett, 363, 33-37.

Zawada, W.M., Zastrow, D.J., Clarkson, E.D., Adams, F.S., Bell, K.P. and Freed, C. R. (1998). Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res, 786, 96-103.

Was this article helpful?

0 0
Brain Blaster

Brain Blaster

Have you ever been envious of people who seem to have no end of clever ideas, who are able to think quickly in any situation, or who seem to have flawless memories? Could it be that they're just born smarter or quicker than the rest of us? Or are there some secrets that they might know that we don't?

Get My Free Ebook

Post a comment